Mounjaro and Gallstones: Risk, Evidence and What to Watch For

Step 1: Understanding why weight-loss medicines and gallstones are connected

The link between gallstones and Mounjaro is not unique to tirzepatide, it is a consequence of losing weight quickly, regardless of the method. When the body metabolises fat rapidly, the liver secretes more cholesterol into bile than the gallbladder can easily manage. That extra cholesterol can crystallise into stones. The faster the weight loss, the higher the theoretical risk, and Mounjaro is capable of producing significant weight reduction; in the SURMOUNT-1 trial published in the New England Journal of Medicine, participants lost around 20–21% of body weight over 72 weeks at the highest dose.

Tirzepatide also slows gastric emptying, which means the gallbladder contracts less frequently after meals. Less frequent contraction allows bile to sit and stagnate, another well-established risk factor for stone formation. So the mechanism is partly the weight loss itself and partly the change in digestive rhythm. Both effects diminish over time as the body adjusts and weight loss slows, but the early months of treatment, when loss is fastest, carry the greatest risk.

None of this means gallstones are common or inevitable. They are listed in the SmPC as a known effect precisely because clinical trials detected them at a rate high enough to warrant reporting, not because most people on Mounjaro develop them. Understanding the mechanism is the starting point for managing the risk sensibly.

Step 2: Recognising symptoms that need urgent attention

Gallstones can be silent for years. When they do cause symptoms, the pattern is fairly distinctive: a cramping or sharp pain in the upper right side of the abdomen, sometimes spreading into the right shoulder or back, often coming on after a fatty meal and lasting anywhere from twenty minutes to several hours. Nausea and vomiting frequently accompany the pain.

If a gallstone blocks the bile duct, the situation becomes more serious. Signs of a blockage or infection (cholecystitis, cholangitis) include fever, chills, yellowing of the skin or whites of the eyes (jaundice), and pain that is severe and continuous rather than cramping and colicky. These are urgent, seek same-day medical help rather than waiting for a routine appointment. The NHS patient information for tirzepatide sets out when to seek medical attention during treatment, and gallbladder symptoms are among the listed reasons to contact a doctor promptly.

It is also worth knowing that the January 2026 MHRA Drug Safety Update for GLP-1 medicines drew attention to pancreatitis as a separate but related concern, severe, persistent stomach pain radiating to the back can be a sign of pancreatitis rather than gallstones, and the two can sometimes be confused. If you are unsure which is causing symptoms, treat it as urgent and let a clinician decide. You can also report any suspected side effect through the MHRA Yellow Card scheme.

Step 3: Practical steps that may lower your risk during treatment

You cannot eliminate the risk entirely, but you can work with your prescriber and diet to keep it as low as reasonably possible. The evidence base for specific interventions in GLP-1-treated patients is still developing, but the principles are drawn from what is known about gallstone prevention during rapid weight loss more broadly.

Eating regular, structured meals matters more than people often realise. The gallbladder contracts to release bile when fat reaches the small intestine, skipping meals or going long stretches without eating reduces those contractions and lets bile pool. Including a small amount of healthy fat at each meal (olive oil, nuts, oily fish) keeps the gallbladder working. Staying well hydrated supports bile flow. Crash-dieting on top of Mounjaro (cutting calories far below what your prescriber has discussed) is exactly the kind of pattern that accelerates stone risk. Our page on how to avoid gallstones on Mounjaro covers the dietary detail more fully, and if you want to go deeper on protective habits, we also explain how to prevent gallstones on Mounjaro with practical guidance on meal timing, hydration and fat intake during treatment.

The tablet sitting on the kitchen counter next to your morning glass of water is a useful reminder: structured daily habits, including consistent meal timing, are part of the treatment, not optional extras.

If you have a history of gallbladder disease, let the prescribing clinician know. That history shapes how often your gallbladder health is monitored and whether additional precautions make sense for you. For a broader look at starting Mounjaro and what the treatment involves, the Mounjaro treatment overview covers the full clinical picture. Our team at nume reviews every patient's medical history in full before issuing a prescription, including any previous gallbladder problems.

Step 4: Existing gallstones and whether Mounjaro is still an option

A previous diagnosis of gallstones or gallbladder disease does not close the door on Mounjaro treatment automatically. Many people with a gallstone history tolerate the medicine well, particularly if the gallstones are small and asymptomatic, or if the gallbladder has already been removed (cholecystectomy). After cholecystectomy, gallstone risk during treatment is effectively eliminated.

For people with active or symptomatic gallbladder disease, the picture is more cautious. A prescriber will weigh the benefit of meaningful weight loss (which itself reduces long-term gallbladder and cardiovascular risk) against the shorter-term risk of exacerbating existing gallbladder disease. There is no blanket rule, which is exactly why the assessment needs to be individual and clinician-led. Our page on taking Mounjaro if you already have gallstones goes into that specific scenario in more depth, and for guidance on what the treatment involves day to day once you have a confirmed gallstone history, you can also read about taking Mounjaro with gallstones and what to monitor alongside your prescriber.

Thinking about how much weight you might realistically lose, and over what timeframe, is also part of the conversation. Pages like losing a stone on Mounjaro give a realistic picture of the pace of weight loss, which directly informs gallstone risk discussions. If you are ready to explore whether Mounjaro is clinically suitable for you, start your free consultation and a GPhC-registered prescriber will review your full history.